These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 11019845

  • 1. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR, Nevill TJ, Balshaw RF, Toze CL, Corr T, Currie CJ, Strong DK, Keown PA.
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [Abstract] [Full Text] [Related]

  • 2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 3. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G.
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
    Dotti G, Gaspari F, Caruso R, Perico N, Remuzzi G, Barbui T, Rambaldi A.
    Haematologica; 2001 Mar; 86(3):311-5. PubMed ID: 11255279
    [Abstract] [Full Text] [Related]

  • 6. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C, Seto W, Taylor T, Saunders EF, Doyle J, Dupuis LL.
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [Abstract] [Full Text] [Related]

  • 7. New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients.
    Parquet N, Reigneau O, Humbert H, Guignard M, Ribaud P, Socié G, Devergie A, Espérou H, Gluckman E.
    Bone Marrow Transplant; 2000 May; 25(9):965-8. PubMed ID: 10800064
    [Abstract] [Full Text] [Related]

  • 8. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.
    Ann Chir; 1998 May; 52(8):716-21. PubMed ID: 9846420
    [Abstract] [Full Text] [Related]

  • 9. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group.
    Transplantation; 2001 Sep 27; 72(6):1024-32. PubMed ID: 11579295
    [Abstract] [Full Text] [Related]

  • 10. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.
    Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Choc M, Wong R.
    Transplantation; 1995 Feb 27; 59(4):505-11. PubMed ID: 7878754
    [Abstract] [Full Text] [Related]

  • 11. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
    Hangler HB, Ruttmann E, Geltner C, Bucher B, Nagiller J, Laufer G, Mueller LC.
    Clin Transplant; 2008 Feb 27; 22(1):35-40. PubMed ID: 18217903
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions.
    Knoop C, Vervier I, Thiry P, De Backer M, Kovarik JM, Rousseau A, Marquet P, Estenne M.
    Transplantation; 2003 Aug 27; 76(4):683-8. PubMed ID: 12973109
    [Abstract] [Full Text] [Related]

  • 13. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
    Jaksch P, Kocher A, Neuhauser P, Sarahrudi K, Seweryn J, Wisser W, Klepetko W.
    J Heart Lung Transplant; 2005 Aug 27; 24(8):1076-80. PubMed ID: 16102443
    [Abstract] [Full Text] [Related]

  • 14. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R, Böger J, Kuse E, Klempnauer J, Nashan B.
    Liver Transpl; 2004 May 27; 10(5):686-91. PubMed ID: 15108262
    [Abstract] [Full Text] [Related]

  • 15. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP, Canter C, Shepherd R, Lassa-Claxton S, Nadler M.
    Pediatr Transplant; 2007 Aug 27; 11(5):524-9. PubMed ID: 17631021
    [Abstract] [Full Text] [Related]

  • 16. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct 27; 36(8):2390-2. PubMed ID: 15561259
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F, Marti HP, Frey FJ, Uehlinger DE.
    Clin Pharmacokinet; 2002 Oct 27; 41(1):59-69. PubMed ID: 11825097
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
    Schrauder A, Saleh S, Sykora KW, Hoy H, Welte K, Boos J, Hempel G, Grigull L.
    Pediatr Transplant; 2009 Jun 27; 13(4):444-50. PubMed ID: 18482216
    [Abstract] [Full Text] [Related]

  • 19. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID, Thomson M, Kelly DA.
    Liver Transpl Surg; 1999 Mar 27; 5(2):107-11. PubMed ID: 10071349
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct 27; 36(8):2386-7. PubMed ID: 15561257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.